Takeda, Watson Sue Mylan Over Generic Actoplus Met XR
Takeda Pharmaceutical Co. Ltd. and Watson Pharmaceuticals Inc. sued Mylan Inc. in New York on Tuesday, alleging Mylan infringed several patents when it sought regulatory approval for a generic version of...To view the full article, register now.
Already a subscriber? Click here to view full article